- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06675331
Mutton Heart Failure Food is Medicine Pilot (Mutton-HF)
Medically Utilized Tailored Traditional Meals to Optimize Nutrition in Heart Failure Pilot Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The American Indian and Alaska Native population has experienced significant cardiovascular health disparities compared with other racial and ethnic groups in the U.S. [1] Heart failure, in particular, causes significant morbidity and mortality in Navajo Nation. For many Navajo patients, similar to other American Indian populations, food insecurity is a major driver of health disparities. [2][3] In fact, qualitative data from our heart failure patient advisory committee have found that 89% of patients with heart failure believe nutrition insecurity is a major barrier to optimal health. Dietary factors are believed to be an important cause of hospitalizations in patients with heart failure and cardiovascular outcomes. There is increasing evidence that direct dietary support, such as produce prescription or provision of medically tailored meals may improve cardiovascular outcomes and disease-specific quality of life. Furthermore, there has been an increased focus in Indigenous communities to reclaim traditional indigenous foods to improve health. However, more evidence of the benefit of traditional Indigenous foods for cardiovascular health is needed.
We, therefore, in discussion with community members and tribal partners at two Indian Health Service (IHS) sites in Navajo Nation, will implement and evaluate the effectiveness of a medically and Native-sourced culturally tailored meal delivery program to improve outcomes in heart failure in rural Navajo Nation. This study will include two phases, with a phase I pilot feasibility study, followed by phase II-a comparativeness effectiveness randomized controlled trial to compare the implementation of our medically and culturally tailored meal delivery program compared to usual care. For phase I, we will conduct a one-arm pilot trial of the MUTTON-HF intervention to determine 1) feasibility of the intervention and outcome assessment and 2) acceptability of the intervention and 3) fidelity of the intervention. We will enroll 20 patients to receive medically tailored meals (14 meals weekly) for 30 days to inform the phase II comparativeness effectiveness trial.
Phase I outcomes will include implementation outcomes such as feasibility and acceptability of the intervention including the various delivery mechanisms and meals as measured by quantitative (i.e. % meals delivered and % meals received by patient) and qualitative methods, of outcome assessment including surveys and laboratory evaluation (% with completed outcome assessment), and fidelity of intervention as measured by quantitative (% meals consumed). We will additionally measure feasibility and acceptability of supporting local food systems by measuring % meals with locally sourced produce and meat, and % sourced from Navajo farmers and ranchers specifically. We will also explore implementation outcomes with community partners including farmers, growers, ranchers, food pantry.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Mexico
-
Tohatchi, New Mexico, United States, 87325
- Tohatchi Health Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age >=18 years
- ICD I50* diagnosis
- Clinical encounter in last 12 months
- Primary care physician at the two IHS sites
- Hospitalization (any-cause) within last 12 months
Exclusion Criteria:
- Hospice care
- Living in acute rehabilitation or skilled nursing facility
- Living outside the Gallup Service Unit (outside 50-mile catchment area)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Meal delivery program
Patients will receive 2 meals daily (14 meals weekly) of medically-tailored meals incorporating traditional Navajo foods, followed by a cooking class at the end of the meal program (meals provided for 4 weeks)
|
Patients will receive medically-tailored meals incorporating local traditional Navajo foods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: Percentage of meals successfully received by the patient
Time Frame: 30 days
|
Proportions of meals that were successfully picked up or received by the patient.
We have determined that >70% would count as success/feasibility of the intervention.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ER visits or hospitalizations
Time Frame: 180 days
|
All cause
|
180 days
|
|
Hospitalization or Emergency Department Visit
Time Frame: 90 Days
|
Hospitalization or Visit to Emergency Department (All-cause)
|
90 Days
|
|
Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Time Frame: Baseline, 30 Days
|
This is a validated score for evaluating quality of life and symptom measures in heart failure patients.
Score ranges from 0-100, with 0 meaning very poor quality of life/symptoms and health status, 100 meaning excellent quality of life/symptom burden/health status.
|
Baseline, 30 Days
|
|
USDA Adult Food Security: Six Item short Form survey
Time Frame: Baseline, 30 Days
|
The six-item short form of the survey module and the associated Six-Item Food Security Scale were developed by researchers at the National Center for Health Statistics in collaboration with Abt Associates Inc.
|
Baseline, 30 Days
|
|
Laboratory Biomarker Data
Time Frame: Baseline, 30 Days
|
Albumin, prealbumin, creatinine, NT-proBNP, HbA1c, Total cholesterol, LDL-C, HDL-C, Triglycerides, CRP
|
Baseline, 30 Days
|
|
Weight/Body Mass Index
Time Frame: Baseline, 30 Days
|
weight and BMI
|
Baseline, 30 Days
|
|
Cultural Connectedness Scale-California
Time Frame: Baseline, 30 Days
|
The Cultural Connectedness Scale (CCS) was developed in Canada by First Nations/Indigenous persons for First Nations/Indigenous persons.
The 29-item CCS consists of three sub-scales: identity, traditions, and spirituality.
This scale ranges from 0-40, with 40 indicating higher levels of cultural connectiveness.
|
Baseline, 30 Days
|
|
Emergency Room Visits
Time Frame: 90 Days
|
ER visits: All cause
|
90 Days
|
|
ER visit for Heart Failure
Time Frame: 90 Days
|
ER visit for volume overload or HF symptoms
|
90 Days
|
|
Heart Failure Hospitalizations
Time Frame: 90 days
|
Hospitalizations for heart failure specifically
|
90 days
|
|
Feasibility: Percentage of meals delivered successfully to the Gallup Food Pantry
Time Frame: 30 days
|
Proportions of meals that were successfully delivered to the Gallup Food Pantry by our community partner and Native-run Kitchen
|
30 days
|
|
Feasibility of Intervention: Delivery/Pick-Up
Time Frame: 30 days
|
We will survey patients post-intervention with question to assess feasibility: "I would rate getting the meals (either picking up or delivery): Very easy, Somewhat easy, Neither easy nor difficult, Somewhat difficult, Very difficult.
|
30 days
|
|
Acceptability of the Intervention (AIM) Measure
Time Frame: 30 days
|
We will evaluate acceptability of the intervention among the patients through quantitative assessment using the validated acceptability of the intervention (AIM) measure
|
30 days
|
|
Net Promoter Score
Time Frame: 30 days
|
We will also assess acceptability of the intervention through assess the Net Promoter Score (i.e.
how likely is it that you would recommend this program to a community member?"), which is a scale 1 (highly unlikely) to 10 (highly likely).
|
30 days
|
|
Fidelity: Consumption
Time Frame: 30 days
|
Patients will also rate meals from 1-5 and the amount of the meal they consumed (none [or only a few bites], less than half, about half, most, or all)
|
30 days
|
|
Acceptability: Taste
Time Frame: 30 days
|
Patients will also be surveyed post-intervention the following questions to assess acceptability: How would you rate the meals overall, in terms of taste (excellent, good, average, below average, bad?"
|
30 days
|
|
Qualitative measures of feasibility and acceptability
Time Frame: 30 days
|
We will also perform semi-structured interviews of patients to assess feasibility and acceptability through qualitative methods.
Semi-structured interviews will be guided by the Consolidated Framework for Implementation Research (CFIR), and we will explore multiple constructs within each CFIR domain that are hypothesized by the study team and based on existing literature to be relevant to acceptability and feasibility of the program
|
30 days
|
|
Feasibility of Supporting Local Food Systems
Time Frame: 30 days
|
We will assess feasibility among our community partners by assessing the validated feasibility of the intervention measure (FIM) among our food pantry partners.
|
30 days
|
|
Feasibility: Local Food Sourcing
Time Frame: 30 days
|
We will also assess the % of meals that include locally sourced ingredients, % of meals sourced by Native suppliers/farmers (produce), % of meals soured by Native ranchers (meat)
|
30 days
|
|
Feasibility of Outcome Assessment
Time Frame: 30 days
|
We will determine the proportion of patients that completes baseline, as well as post-implementation survey and laboratory data. We will consider ≥ 80% completion rates as a success. |
30 days
|
|
Fidelity of Intervention
Time Frame: 30 days
|
We will assess fidelity of the intervention by evaluating:
|
30 days
|
|
Adoption of Intervention
Time Frame: 30 days
|
We will survey participants post-intervention the following using a Likert scale:
|
30 days
|
|
Diet Quality
Time Frame: Baseline and 30 days
|
We will assess diet quality using the 10-item DSQ [10] with an addition question to assess traditional Dine food intake (During the past month, how often did you eat traditional Diné foods (such as blue corn mush, steamed, roasted or dried corn, sumac berries, mutton, local varieties of squash or beans) at baseline and at the end of the intervention.
|
Baseline and 30 days
|
|
Physical Activity
Time Frame: Baseline and 30 days
|
We will evaluate how much physical activity/exercise patients are participating in weekly at baseline, and at 30 days by asking patients to estimate the number of minutes weekly that they are participating in formal exercise or physical activity.
|
Baseline and 30 days
|
|
General Health Status
Time Frame: Baseline and 30 days
|
We will evaluate patients' general health status using a single general health status question (would you say that in general your health is excellent, very good, good, fair, or poor) at baseline and post-intervention
|
Baseline and 30 days
|
|
KCCW12-PL Physical Limitation Score
Time Frame: 30 days
|
Subsection of KCCQ-12 Summary
|
30 days
|
|
KCCQ12-PL Physical Limitation Score
Time Frame: 30 days
|
Subsection of KCCQ12 looking at physical limitation
|
30 days
|
|
KCCQ12-SF Symptom Frequency Score
Time Frame: 30 Days
|
Subsection of KCCQ-12 looking at frequency of symptoms
|
30 Days
|
|
KCCQ-QL
Time Frame: 30 Days
|
Subsection of KCCQ-12 that looks at quality of life
|
30 Days
|
|
KCCQ-SL Social Limitation Score
Time Frame: 30 days
|
Subsection of KCCQ-12 looking at social limitation
|
30 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication and Medical Therapy Adherence
Time Frame: 30 days
|
Additional exploratory outcomes will prescription rates for all medication as well as guideline-directed medical therapy specifically (for heart failure with reduced ejection fraction this would include ACEi/ARB/ARNI, Beta-blocker, SGLT2 inhibitors, and mineralocorticoid receptor antagonist; for HFpEF this would include SGLT2 inhibitors).
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lauren Eberly, MD, MPH, Indian Health Service (IHS)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10072024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Medically Tailored Meal Program with Traditional Navajo Foods
-
University of PennsylvaniaBrigham and Women's Hospital; American Heart Association; Indian Health Service...CompletedHeart FailureUnited States